Dudnik Y - Search Results

1

Unexpected Adverse Events of Immune Checkpoint Inhibitors.

Shalata W, Yakobson A, Cohen AY, Goldstein I, Saleh OA, Dudnik Y, Rouvinov K. Shalata W, et al. Among authors: dudnik y. Life (Basel). 2023 Jul 29;13(8):1657. doi: 10.3390/life13081657. Life (Basel). 2023. PMID: 37629514 Free PMC article.

2

Are we facing a cure in lung cancer?-KEYNOTE-001 insights.

Cohen AY, Kian W, Roisman LC, Levitas D, Peled N, Dudnik Y. Cohen AY, et al. Among authors: dudnik y. Ann Transl Med. 2019 Sep;7(Suppl 6):S215. doi: 10.21037/atm.2019.08.87. Ann Transl Med. 2019. PMID: 31656794 Free PMC article. No abstract available.

3

Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer.

Kian W, Roisman LC, Wallach N, Levitas D, Yakobson A, Dudnik Y, Peled N, Rouvinov K. Kian W, et al. Among authors: dudnik y. J Thorac Dis. 2020 Aug;12(8):3918-3920. doi: 10.21037/jtd.2020.04.45. J Thorac Dis. 2020. PMID: 32944298 Free PMC article. No abstract available.

4

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy.

Yakobson A, Alguayn W, Shalata W, Levin D, Kian TA, Korngreen A, Gibbs R, Salah MA, Benzion S, Lavrenkov K, Roisman LC, Dudnik Y, Peled N, Refaely Y, Kian W. Yakobson A, et al. Among authors: dudnik y. Case Rep Oncol. 2021 Mar 3;14(1):309-317. doi: 10.1159/000510806. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33776722 Free PMC article.

5

Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature review.

Shalata W, Waichenberg L, Massalha I, Dudnik Y, Rouvinov K, Yakobson A. Shalata W, et al. Among authors: dudnik y. Anticancer Drugs. 2021 Nov 1;32(10):1142-1145. doi: 10.1097/CAD.0000000000001115. Anticancer Drugs. 2021. PMID: 34232946

6

Metastatic small cell lung cancer - an aggressive disease: a case report and literature review.

Shalata W, Massalha I, Rouvinov K, Oscar E, Toker M, A-J A, Dudnik Y, Yakobson A. Shalata W, et al. Among authors: dudnik y. Anticancer Drugs. 2021 Nov 1;32(10):1138-1141. doi: 10.1097/CAD.0000000000001119. Anticancer Drugs. 2021. PMID: 34232947

7

Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience.

Shalata W, Zolnoorian J, Migliozzi G, Jama AA, Dudnik Y, Cohen AY, Meirovitz A, Yakobson A. Shalata W, et al. Among authors: dudnik y. Int J Mol Sci. 2023 Mar 21;24(6):5938. doi: 10.3390/ijms24065938. Int J Mol Sci. 2023. PMID: 36983011 Free PMC article.

8

Radiotherapy-Induced Atrial Myxoma: A Case Report and Literature Review.

Shalata W, Massalha I, Ishay SY, Chernomordikova E, Jama AA, Rouvinov K, Dudnik Y, Yakobson A. Shalata W, et al. Among authors: dudnik y. Life (Basel). 2023 Jul 19;13(7):1585. doi: 10.3390/life13071585. Life (Basel). 2023. PMID: 37511961 Free PMC article.

9

Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors.

Yakobson A, Rouvinov K, Cohen AY, Goldstein I, Abu Saleh O, Solomon A, Dudnik Y, Shalata W. Yakobson A, et al. Among authors: dudnik y. J Pers Med. 2023 Aug 30;13(9):1340. doi: 10.3390/jpm13091340. J Pers Med. 2023. PMID: 37763109 Free PMC article.

10

Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer.

Shalata W, Yakobson A, Dudnik Y, Swaid F, Ahmad MS, Abu Jama A, Cohen AY, Agbarya A. Shalata W, et al. Among authors: dudnik y. Biomedicines. 2023 Aug 31;11(9):2438. doi: 10.3390/biomedicines11092438. Biomedicines. 2023. PMID: 37760878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page